Nippon India Pharma Fund - Direct (IDCW)
Nippon India Pharma Fund - Direct (IDCW) Overview
Holdings Distribution
Top Holdings
Peer Comparison
| Fund Name | 1Y | 3Y | 5Y |
|---|---|---|---|
| Nippon India Pharma Fund - Direct (IDCW) | 9.29% | 25.62% | 14.24% |
| Abakkus Small Cap Fund - Direct (G) | N/A | N/A | N/A |
| Canara Robeco Banking and Financial Services Fund - Reg (G) | N/A | N/A | N/A |
| Canara Robeco Banking and Financial Services Fund - Reg (IDCW) | N/A | N/A | N/A |
| Canara Robeco Banking and Financial Services Fund - Dir (G) | N/A | N/A | N/A |
| Canara Robeco Banking and Financial Services Fund - Dir (IDCW) | N/A | N/A | N/A |
Scheme Information
Nippon India Pharma Fund - Direct (IDCW) was launched on 01/01/2013. The fund manages ₹8,365 Cr in assets. Its current expense ratio is 1.48%.
Fund Manager: Sailesh Raj Bhan
Returns Calculator
Calculate your investment growth with SIP or Lumpsum.
FAQs on Nippon India Pharma Fund - Direct (IDCW)
The current expense ratio of Nippon India Pharma Fund - Direct (IDCW) is 1.48%.
The AUM of Nippon India Pharma Fund - Direct (IDCW) is ₹8,365 crore.
Log in to your investment platform, select the fund, enter units or amount, and confirm the redemption request.
Yes, Nippon India Pharma Fund - Direct (IDCW) allows both SIP and lump sum investments.
The latest NAV is ₹440.05.
Minimum SIP starts from ₹100.
Redemption can be done via AMC website or your investment platform.
